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NADPH oxidases derived reactive oxygen species (ROS) play an important role in
vascular function and remodeling in hypertension through redox signaling processes.
Previous studies demonstrated that protein disulfide isomerase (PDI) regulates Nox1
expression and ROS generation in cultured vascular smooth muscle cells. However, the
role of PDI in conductance and resistance arteries during hypertension development
remains unknown. The aim of the present study was to investigate PDI expression
and NADPH oxidase dependent ROS generation during hypertension development.
Mesenteric resistance arteries (MRA) and thoracic aorta were isolated from 6, 8,
and 12 week-old spontaneously hypertensive (SHR) and Wistar rats. ROS production
(dihydroethidium fluorescence), PDI (WB, imunofluorescence), Nox1 and NOX4 (RT-PCR)
expression were evaluated. Results show a progressive increase in ROS generation
in MRA and aorta from 8 to 12 week-old SHR. This effect was associated with a
concomitant increase in PDI and Nox1 expression only in MRA. Therefore, suggesting
a positive correlation between PDI and Nox1 expression during the development of
hypertension in MRA. In order to investigate if this effect was due to an increase in
arterial blood pressure, pre hypertensive SHR were treated with losartan (20mg/kg/day
for 30 days), an AT1 receptor antagonist. Losartan decreased blood pressure and ROS
generation in both vascular beds. However, only in SHR MRA losartan treatment lowered
PDI and Nox1 expression to control levels. In MRA PDI inhibition (bacitracin, 0.5mM)
decreased Ang II redox signaling (p-ERK 1/2). Altogether, our results suggest that PDI
plays a role in triggering oxidative stress and vascular dysfunction in resistance but not
in conductance arteries, increasing Nox1 expression and activity. Therefore, PDI could
be a new player in oxidative stress and functional alterations in resistance arteries during
the establishment of hypertension.
Keywords: protein disulfide isomerase, hypertension, NADPH oxidase, Nox1, reactive oxygen species, mesenteric
resistance arteries, aorta
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Introduction
Among the factors involved in the pathophysiology of hyper-
tension evidence indicates an important role of reactive oxy-
gen species (ROS) (Pechanova et al., 2006). Several studies asso-
ciate hypertension with high concentrations of ROS in animal
models (Heitzer et al., 1999; Kitamoto et al., 2000; Beswick
et al., 2001) and in humans (Lacy et al., 1998; Lee et al., 2003).
Indeed, the increase in ROS in spontaneously hypertensive rats
(SHR) may contribute to left ventricular hypertrophy, coronary
artery disease (Shah and Channon, 2004), kidney damage (Adler
et al., 2004), endothelial dysfunction (Rodrigues et al., 2006) and
remodeling of pulmonary arteries (Demarco et al., 2008).
An important source of ROS in the cardiovascular system is
the NADPH oxidase family of enzymes. These enzymes gener-
ate superoxide, that can reduce the bioavailability of nitric oxide
(NO) as well as serve as a precursor for other species such as
H2O2 and ONOO
− (Rey et al., 2001). The NADPH oxidase com-
prises a family of enzymes known as Nox that catalyze the reduc-
tion of molecular oxygen generating superoxide. Although all
Nox isoforms are transmembrane proteins capable of generating
ROS, they differ in distribution and cellular localization, asso-
ciation with regulatory subunits, ROS generated and activation
mechanisms. These differences are responsible for the different
functions of Nox and confer specificity to the action of ROS
as second messengers, making the generation of these species
a controlled and compartmentalized event. Unlike phagocytic
NADPH oxidase, vascular NADPH oxidase can be regulated by
gene transcription of its subunits. Thus, NADPH oxidase activ-
ity can be regulated through assembly of the regulatory sub-
units to the membrane or by increased expression of the enzyme
(Brandes and Schroder, 2008).
In the cardiovascular systemNoxes can regulate vascular func-
tion proliferation, migration and hypertrophy of vascular smooth
muscle cells (VSMC) as well as cell differentiation and angio-
genesis (Cave et al., 2006; Garrido and Griendling, 2009). Some
aspects differ between Nox1 and Nox4 isoforms. Nox 4 is located
in the endoplasmic reticulum and nucleus (Ambasta et al., 2004)
and generates H2O2 (Takac et al., 2011) constitutively and inde-
pendent of cytosolic subunits (Ellmark et al., 2005). On the other
hand, in VSMCNox1 is located in caveolae (Hilenski et al., 2004),
plasma membrane and endosomes (Miller et al., 2010) and gen-
erates O−2 . The generation of ROS by Nox1 can be stimulated
by Ang II. Initially, the binding of Ang II to the AT1 recep-
tor activates protein kinase C which phosphorylates p47phox.
This initial phase of ROS generation is rapid and occurs within
seconds after Ang II stimulation. Maintenance of Nox1 activa-
tion requires transactivation of EGFR and activation of ERK1/2
which leads to an increase in Nox1 expression and vascular
smooth muscle cell proliferation (Stanic et al., 2010). In fact, sev-
eral studies have shown that expression of Nox1 is increased in
injured arteries of Wistar rats (Szocs et al., 2002), of diabetic
rats (Wendt et al., 2005) and in SHR (Matsuno et al., 2005; Tabet
et al., 2008). Furthemore, mice with deficiency of Nox-1 show a
decrease in blood pressure (Gavazzi et al., 2006).
Studies from our group identified PDI as a protein which
associates with NADPH oxidase subunits regulating Ang II
dependent ROS generation in VSMC. Moreover, this association
was also demonstrated in leukocytes (Santos et al., 2009; Paes
et al., 2011) and endothelial cells (Laurindo et al., 2008).
Interestingly, Nox1 is associated with an increased gen-
eration of ROS in Ang II infusion hypertension models
(Dikalova et al., 2005). Taken together, these studies indicate a
close association between the expression of PDI and the expres-
sion and activity of vascular NADPH oxidases. Therefore, under-
standing the role of PDI in the activation of vascular NADPH
oxidases in diseases such as hypertension may provide a new
approach for the development of new forms of therapeutic inter-
vention in the treatment of this disease. Thus, the goal of this
study was to determine PDI expression and NADPH oxidase
dependent ROS generation and signaling in conductance and
resistance arteries during hypertension development.
Materials and Methods
Animals and Tissue Preparation
All procedures carried out were approved by the Ethics Commit-
tee for Animal Experimentation of the Institute of Biomedical
Sciences (ICB) at University of São Paulo (São Paulo, Brazil) in
accordance with the guidelines from the Brazilian College for
Animal Experimentation (COBEA) under Federal Law 11794.
Male SHR and Wistar rats were housed in climatically controlled
environment (12 h light–dark cycle at 22◦C) with access to rodent
chow and water ad libitum.
Measurement of Blood Pressure
Systolic blood pressure was determined in conscious rats using
an indirect tail-cuff method (pneumatic transducer, PowerLab
4/S, AD Instruments Pty Ltd), a few days before experimenta-
tion. Rats were preheated at 40◦C for 5min, and three stable
consecutive measurements of blood pressure were averaged.
Anti Hypertensive Treatment
In order to investigate the effect of AT1 activation in PDI expres-
sion during the development of hypertension, pre hypertensive,
7 week-old SHR and Wistar rats were treated with the AT1
receptor antagonist, Losartan (20mg/kg/day) by gavage for
30 days (Koprdova et al., 2009). A separate group of animals
received vehicle (water) and was used as control. Untreated
or treated age- and weight-matched SHR or Wistar rats were
decapitated and thoracic aorta and mesenteric arteries were
removed. Afterwards, arteries were washed with ice-cold PBS,
and maintained at 4◦C in Krebs-Henseleit (KHS) solution
(112.0mM NaCl, 4.7mM KCl, 2.5mM CaCl2, 1.1mM KH2PO4,
1.2mM MgSO4, 25.0mM NaHCO3, and 11.1mM glucose). The
samples were carefully dissected and processed according to the
techniques described below.
Detection of Reactive Oxygen Species (ROS)
Generation
ROS generation was measured by detection of fluorescent
dihidroethidium (DHE) oxidation products. In the presence
of superoxide and other reactive species, DHE is oxidized
to 2-Hydroxyethidium and ethidium, which are trapped by
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intercalation with DNA resulting in bright red fluorescence
(excitation: 480; emission: 580 nm). Thoracic aorta and mesen-
teric arteries of SHR and Wistar rats were embedded in Tissue
Tek O.C.T. Compound (Sakura Finetek, Torrance, CA, USA).
Unfixed frozen cross sections (5µm) were incubated with DHE
(5µmol/L; Molecular Probes) diluted in phosphate buffer with
DTPA (100µmol/L); in a light-protected and humidified cham-
ber at 37◦C for 30min. A group of artery slices were treated with
PEG-SOD (150U/mL) for 30min before incubation with DHE.
Fluorescence was detected with a 490–590 nm long-pass filter,
under a microscope (Axiovert, Zeiss) with a 20× objective lens
coupled to a digital camera. Fluorescent images were recorded
with exposure intensity adjusted relatively to 6 weeks Wistar
FIGURE 1 | Development of systolic blood pressure (SBP) increases in
spontaneously hypertensive rats (SHR). SBP was measured by tail-cuff
method in 6, 8 and 12 week-old SHR and Wistar rats. Results are expressed
as mean ± SEM of n = 5 animals. *p < 0.05 vs. Wistar; +p < 0.05 vs. SHR 6
weeks and #p < 0.05 vs. SHR 6 and 8 weeks.
rats. Fluorescent images were analyzed by measuring the mean
optical density of the fluorescence in a computer system (Image
J R©). This fluorescence was evaluated in at least three different
locations in each image and normalized by area.
Quantitative PCR Analysis
Mesenteric arteries and aortas were removed, frozen in liq-
uid nitrogen and homogenized. RNA was isolated by trizol
chloroform method. Synthesis of cDNA was carried out with
MMLV (Promega). Quantitative PCR reactions were performed,
recorded, and analyzed using the Corbett Research system
(Corbett Life Sciences, Sydney, Australia). The specificity
of the SYBR R© green assay was confirmed by melting-point
analysis. Relative expressions of targeted genes were calculated
from the cycle threshold (Ct) value using the 1Ct method for
quantification. Gene expression of hypoxanthine phosphoribo-
syltransferase mRNA (HPRT) was used for normalization. All
oligonucleotides and reagents utilized in this protocol were pur-
chased from Invitrogen (Carlsbad, CA, USA). Primer sequences
were as followed:
Nox1: sense – 5′-TTCCCTGGAACAAGAGATGG-3′, and
antisense – 5′-GACGTCAGTGGCTCTGTCAA-3′;
Nox4: sense – 5′-CTGGAAGAACCCAAGTTCCA-3′, and
antisense – 5′-CGGATGCATCGGTAAAGTCT-3′;
HPRT: sense – 5′-TTTTGCTGACCTGCTGGATTAC-3′,
and antisense: – 5′-TACTTTTATGTCCCCCGTTGA-3′.
Immunofluorescence Assay
Mesenteric arteries and aorta segments were embedded in Tis-
sue Tek O.C.T. Compound (Sakura Finetek, Torrance, CA,
USA). Tissues sections (7–14µm) were obtained in a cryostat
(Leica Microsystems, Germany, model CM1850) and mounted
FIGURE 2 | ROS generation increases during hypertension
development in mesenteric resistance arteries and aorta from
hypertensive rats. Analysis of dihydroethidium (DHE; 5µmol/L) derived
fluorescence (A,C) and quantification (B,D) in slices of mesenteric resistance
arteries (A,B) and aorta (C,D) of 6, 8, and 12 week-old SHR and Wistar rats.
A set of serial sections were treated with PEG SOD (150U/mL) for 30min
before incubation with DHE and used as experiment control. Images are
representative of three different experiments. Images were acquired using a
20× objective lens with exposure intensity adjusted relatively to 6 weeks
Wistar. Results are expressed as mean ± SEM of n = 3 experiments.
*p < 0.05 vs. Wistar; +p < 0.05 vs. 6 weeks SHR; and #p < 0.05 vs. 6, 8,
and 12 weeks SHR + PegSOD.
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FIGURE 3 | Nox1 but not Nox4 expression increases only in
mesenteric resistance arteries during hypertension development.
Nox1 and Nox4 mRNA levels were detected by RT-PCR. Nox1 mRNA
expression was increased in mesenteric arteries (A) from 8 and 12
weeks SHR while in aorta (C) there was no difference among groups.
Nox4 mRNA expression was increased in mesenteric arteries (B) from
12 weeks SHR, while in aorta (D) Nox4 was increased in 8 and 12
weeks SHR. Results were normalized to HPRT mRNA and are
expressed as fold increase as compared to 6 weeks Wistar. Results
are expressed as mean ± SEM of n = 5 experiments. *p < 0.05 vs.
Wistar +p < 0.01 vs. SHR 6 weeks; #p < 0.05 vs. SHR 6 and 8
weeks.
FIGURE 4 | PDI expression increases only in mesenteric
resistance arteries during hypertension development. In
mesenteric arteries, PDI expression detected by immunofluorescence
(A, green) and western blot (B) was increased in 8 and 12 week-old
SHR. In aorta, PDI expression detected by immunofluorescence (C)
and western blot (D) showed no difference between Wistar and SHR.
Images are representative of three different experiments. Images were
acquired using a 20× objective lens with exposure intensity adjusted
relatively to 6 week-old Wistar. PDI expression was normalized to
β-actin. Results are expressed as percentage of 6 week-old Wistar
and represent mean ± SEM of n = 6 experiments. *p < 0.05 vs.
Wistar; +p < 0.05 vs. Wistar 6 weeks.
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in gelatized slides. After fixing in paraformaldehyde 4% (30min),
sections were incubated with a blocking buffer containing 0.3%
Triton X-100, 2% normal goat serum and 1% BSA for 2 h. Sec-
tions were then incubated overnight with anti-PDI antibody
(anti-mouse anti-PDI 1:100; Thermo scientific, USA) diluted in
blocking buffer followed by incubation with a FITC-coupled
secondary antibody (goat anti-mouse – FITC, 1:200) at room
temperature for 2 h. Controls for immunostaining included the
omission of the primary antibody and its substitution for normal
goat serum, which completely eliminated staining. Immunore-
activity was visualized by fluorescence microscopy (Axioskop,
Zeiss) using a x20 objective lens coupled to a digital camera. Flu-
orescent images were recorded with exposure intensity adjusted
relative to Wistar 6 weeks.
Western Blotting
Frozen mesenteric arteries and aortas were homogenized in cold
lysis buffer [50mmol/L of Tris/HCl (pH 7.4), 5mmol/L of EGTA,
2mmol/L of EDTA, 0.1mmol/L of PMSF, 1mmol/L of pep-
statin A, 1mmol/L of leupeptin, and 1mmol/L of aprotinin].
Homogenates were centrifuged at 13000 g for 30min. Equal
amounts of proteins (20 or 75µg) were loaded on a 10% sodium
dodecyl sulfate polyacrylamide gel (SDS-PAGE), transferred onto
a nitrocellulose membrane and incubated overnight at 4◦C with
primary antibody. Proteins were detected by infrared laser scan-
ner using an Odyssey CLX 100 (Li-Cor Biosciences, Nebraska,
USA). Densitometry was determined using the Odyssey package
FIGURE 5 | Age-dependent differences in eNOS expression during the
development of hypertension. eNOS expression in aortas detected by
western blot (WB) was increased in 6, did not change in 8 and decreased in
12 week-old SHR and compared to Wistar rats. Protein expression was
normalized to α-actin. Upper panel shows a representative blot of five
experiments. Results are expressed as percentage of respective Wistar and
represent mean ± SEM. *p < 0.05 vs. age-matched Wistar.
and quantified through computer analysis, using the Image J
program (Molecular Dynamics, Sunnyvale, CA, USA). Antibod-
ies used were: anti-PDI from Thermo Scientific (Rockford, IL,
USA), anti- ERK 1/2 and phospho ERK 1/2 from Cell Signal-
ing (Danvers, MA, USA), anti eNOS BDTransduction (NJ, USA),
anti-β-actin and anti-α actin from Sigma Aldricht (St Louis, MO,
USA). Results were normalized to total non phosphorylated pro-
tein or with α- or β-actin in the same sample run on the same
gel/membrane.
Statistical Analysis
The results were expressed as mean ± S.E.M. Statistical compar-
isons were performed using One Way or Two Way analysis of
variance (ANOVA) with appropriate post-hoc analysis. A value of
P < 0.05 was considered significant.
Results
Hypertension Development is Accompanied by
Oxidative Stress and Increased Nox-1/ PDI
Expression Only in Mesenteric Resistance
Arteries
Figure 1 shows that SHR were normotensive at 6 weeks of age;
however, at 8 weeks of age SHR presented an increase in blood
pressure as compared to Wistar rats, which was even higher at
12 weeks and this stage was considered a phase of established
hypertension.
ROS generation increased in 8 and 12 week-old SHR in
both mesenteric resistance arteries (Figures 2A,B) and aorta
(Figures 2C,D). Interestingly, ROS generation in aorta of SHR
was already increased at 6 weeks when the animals were still
normotensive (Figures 2C,D).
A progressive increase in Nox1 expression was observed
in mesenteric resistance arteries from 8 to 12 weeks in SHR
(Figure 3A). On the other hand, in aorta there was no differ-
ence in Nox1 expression between SHR and Wistar rats in any of
the age-matched animals studied (Figure 3C). Nox 4 expression
FIGURE 6 | AT1R antagonist decreases systolic blood pressure (SBP)
in hypertensive rats. Values of SBP measured by tail-cuff method in SHR
and Wistar rats. A subgroup of 7 week-old SHR was treated with Losartan
(Los, 20mg/kg/day) during 30 days. Results are expressed as mean ± SEM of
n = 5 rats. *p < 0.05 vs. Wistar and #p < 0.05 vs. SHR.
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FIGURE 7 | AT1R antagonist decreases ROS generation in
mesenteric resistance arteries and aorta from hypertensive rats.
Analysis of dihydroethidium (DHE) derived fluorescence (A,C) and
quantification (B,D) show that losartan (20mg/kg/day, 30 days)
treatment reduces the enhanced ROS generation in mesenteric
resistance arteries (B) and aorta (D) from SHR. A set of serial
sections were treated with PEG SOD (150U/mL) for 30min before
incubation with DHE and used as experiment control. Images are
representative of three different experiments and were acquired using a
20× objective lens with exposure intensity adjusted relatively to Wistar
non treated rats (control). Results are expressed as mean ± SEM of
n = 3 experiments. *p < 0.05 vs. Wistar; #p < 0.05 vs. control SHR.
was increased only in 12 week-old mesenteric resistance arteries
(Figure 3B), while in aorta there was a progressive increase from
8 to 12 weeks in SHR (Figure 3D).
Interestingly, PDI expression followed the same pattern of
increase as Nox1, increasing in mesenteric resistance arteries
from 8 to 12 week-old SHR (Figures 4A,B), while in aorta there
was no difference among groups (Figures 4C,D). These data
suggest a positive correlation between Nox-1/ PDI expression
and ROS generation during the development of hypertension
only in mesenteric resistance arteries.
In order to verify protein expression of endothelial NO
synthase (eNOS) during the development of hypertension we
performedWestern Blot experiments. Figure 5 shows eNOS pro-
tein expression is increased in 6 week, did not change in 8 week
and decreased in 12 week SHR aortas as compared toWistar rats.
AT1 Receptor Antagonism Reduces Oxidative
Stress and Nox-1/ PDI Expression in Mesenteric
Resistance Arteries
Losartan treatment was able to progressively decrease blood
pressure in SHR to control levels (Figure 6).
Furthermore, AT1 receptor antagonism blocked the
increased ROS generation in both mesenteric resistance
arteries (Figures 7A,B) and aorta (Figures 7C,D) of SHR. The
incubation of the arterial segments with Peg-SOD decreased
DHE fluorescence, which implicates superoxide as one of the
oxidants generated in these vessels (Figures 7A–D). In addi-
tion, increased Nox1 gene expression observed only in SHR
mesenteric resistance arteries was reversed by losartan treatment
(Figures 8A,C). Nox4 gene expression increased in non treated
(control) SHR mesenteric resistance arteries and aortas and AT1
antagonism blocked this effect in both vessels (Figures 8B,D,
respectively).
Similarly to Nox1, the increased expression of PDI in
mesenteric resistance arteries was reduced by losartan treat-
ment (Figures 9A,B). However, neither hypertension nor losar-
tan treatment changed PDI expression in aorta (Figures 9C,D).
These results indicate a relationship between Nox1 and PDI in
Ang II-induced ROS generation in SHR mesenteric resistance
arteries.
PDI Inhibition Decreases Ang II-induced Redox
Signaling in Resistance Arteries
We then questioned whether PDI plays a role in Ang II redox
signaling in mesenteric resistance arteries. Isolated mesenteric
arteries from SHR and Wistar rats were acutely stimulated with
Ang II (100 nmol/L) for 5min in the presence of the PDI
inhibitor bacitracin (0.5mmol/L). An increased Ang II-induced
phosphorylation of ERK 1/2 was observed in mesenteric resis-
tance arteries of SHR when compared to Wistar rats. PDI inhibi-
tion significantly decreased ERK 1/2 activation by Ang II in both
SHR and Wistar mesenteric arteries (Figure 10).
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FIGURE 8 | AT1R antagonist decreases Nox1 expression only in
resistance arteries and Nox 4 in both vessels from hypertensive rats.
Nox1 and Nox4 mRNA levels detected by RT-PCR. Nox1 mRNA expression
was decreased in mesenteric resistance arteries (A) from SHR treated with
losartan (20mg/kg/day, 30 days), while in aorta (C) there was no change.
Nox4 mRNA expression increased in both mesenteric arteries (B) and aorta
(D) from SHR treated and this effect was reversed after Losartan treatment.
Results were normalized to HPRT mRNA and are expressed as fold increase
as compared to Wistar non treated rats (control). Data represent mean ± SEM
of n = 5 experiments. *p < 0.05 vs. Wistar, #p < 0.05 vs. control SHR.
Discussion
Previous studies from our group revealed a close relationship
between PDI and NADPH oxidase. In particular in VSMCs,
PDI associates with NADPH oxidase subunits (Janiszewski et al.,
2005) regulates basal NADPH oxidase activity and Ang II-
induced activity (Fernandes et al., 2009), and is involved in
PDGF-induced Nox1-dependent migration (Pescatore et al.,
2012). However, involvement of PDI in hypertension vascular
dysfunction associated with increased NADPH oxidase activity
has not been investigated. In this study we show for the first time
that PDI expression increases during hypertension development
in resistance but not in conductance arteries. Furthermore, we
observed that the increase in PDI is accompanied by an increase
in Nox1, but not Nox4, expression and that PDI plays a role in
Ang II-induced redox signaling in hypertension.
Hypertension is widely known to be associated with high lev-
els of ROS and an increase in Nox1 activity and expression.
Nox1 transgenic mice show augmented ROS levels and increased
pressor and hypertrophic responses to Ang-II. Therefore, Nox1-
derived ROS could contribute to increased wall thickness in
hypertension development (Dikalova et al., 2005). In the present
study we used spontaneously hypertensive rat (SHR), a model of
genetic hypertension. Our data confirms previous studies show-
ing an increase in blood pressure (BP) from 6 to 12 weeks of
age (Nabha et al., 2005). In addition, it has been shown that
FIGURE 9 | Losartan treatment decreases PDI expression only in
resistance arteries from hypertensive rats. In mesenteric arteries losartan
treatment (20mg/kg/day, 30 days) decreased PDI expression in SHR as
shown by immunofluorescence (A) and western blot (B). In aorta,
immunofluorescence (C) and western blot (D) showed no difference in PDI
expression in Wistar and SHR before and after treatment with losartan. Images
are representative of three different experiments and were acquired using a
20× objective lens with exposure intensity adjusted relatively to Wistar non
treated rats (control). PDI expression was normalized to β-actin expression.
Results are expressed as percentage of Wistar control and represent mean ±
SEM of n = 4 experiments. *p < 0.05 vs. control Wistar and +p < 0.05 vs.
control SHR.
SHR exhibit high levels of ROS in the kidney only a few weeks
after birth, before the rise in blood pressure or in inflamma-
tory markers, which is suggestive that ROS enhancement pre-
cedes the increment in blood pressure (Chabrashvili et al., 2002).
However, in the vasculature there is still some controversy. We
investigated ROS generation, PDI and Nox expression in resis-
tance (mesenteric arteries) and conductance arteries (aorta) in
normotensive (6 week-old), pre-hypertensive (8 week-old) and
hypertensive (12 week-old) SHR. We show here that ROS gen-
eration increases in mesenteric arteries concomitantly with the
increase in blood pressure or else, after 8 weeks. In contrast, in
aorta increased ROS generation is already present in 6 week-old
SHR, despite normal blood pressure. Therefore our results con-
firm previous studies (Nabha et al., 2005) which show that at least
in the aorta increase in ROS generation precedes the increase in
blood pressure. Furthermore, we show that Nox isoform expres-
sion differed in resistance and conductance arteries during the
establishment of hypertension. Nox1 was the source of ROS in
resistance arteries and Nox4 in conductance ones. Additionally,
our data demonstrate that only in mesenteric resistance arter-
ies ROS generation seems to be Nox1 dependent. In fact, high
expression of Nox1, and Nox4 was reported in VSMC isolated
from mesenteric arteries of 12 week-old SHR but in accordance
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FIGURE 10 | PDI inhibition decreases Ang II induced ERK 1/2 activation
in mesenteric resistance arteries of Wistar and SHR. Ang II rapidly
induced ERK 1/2 phosphorylation (p-ERK; 5min) and this activation is
increased in SHR mesenteric arteries as compared to Wistar. PDI inhibition
(Bacitracin 0.5mmol/L) significantly abolished p-ERK 1/2 in mesenteric arteries
of both strains. Upper panel shows a representative blot for three experiments.
Bar graph indicates relative quantification of p-ERK content expressed as the
ratio between pERK and ERK 1/2 and normalized to the vehicle group, taken
as 100%. Results are expressed as percentage of Wistar vehicle and
represent mean ± SEM. *p < 0.05 vs. respective Ang II; +p < 0.05 vs. SHR
Ang II; #p < 0.05 vs. respective vehicle.
to our findings, only siNox1 inhibited ROS production in these
cells (Briones and Touyz, 2010). In aorta, some authors show
high levels of Nox1, 2, and 4 (Akasaki et al., 2006; Li et al., 2010),
while others show higher expression of Nox1 and 2, but not Nox4
(Wind et al., 2010). Nevertheless, the age of these rats was either
not informed or older than the ones used here.
Interestingly, PDI expression only increased in mesenteric
arteries, and concomitantly to Nox1 expression, despite previ-
ous data from our group which showed that PDI associates with
both Nox1 and Nox4 (Janiszewski et al., 2005). In fact, evidence
of a closer relationship between Nox1 and PDI in VSMCs, was
demonstrated recently. Overexpression of PDI in aortic VSMCs
resulted in an increase in Nox1 expression, while silencing of
PDI decreased Nox1 expression. In contrast, neither PDI over-
expression nor silencing altered Nox4 expression in these cells
(Fernandes et al., 2009). Furthermore, PDI also regulates Ang II
and PDGF induced effects on Nox1 expression, while no effect
was observed in Nox 4 (Fernandes et al., 2009; Pescatore et al.,
2012). The present data corroborates these studies and provides a
potential role for PDI in Nox1 derived ROS generation in hyper-
tension. Therefore, although, the exact mechanisms regarding
PDI-NADPH oxidase interaction remains to be elucidated, the
present study is the first to provide evidence for the role of PDI
in Nox1 signaling in hypertension.
Our data also show differential eNOS expression in aorta
during development of hypertension. Particularly, we show an
increase of eNOS in aorta in the early stages of the disease.
Corroborating these data previous studies have shown that 3
week old SHR present an enhancement of aorta and kidney pro-
tein expression of eNOS and NO generation, suggesting that NO-
pathway is upregulated in SHR before the onset of hypertension
(Vaziri et al., 1998). On the other hand, the present data demon-
strated a reduction of eNOS expression in aorta of 12 week old
SHR. In this context, the literature shows contradictory results of
eNOS expression in aorta of SHR after established hypertension.
Indeed this expression has been shown to be enhanced (Vaziri
et al., 1998) or reduced (Rodriguez-Rodriguez et al., 2007; Xu and
Liu, 2013). Also, eNOS activation is decreased (Filho et al., 2013)
and ROS production in aorta of SHR was associated with eNOS
uncoupling (Li et al., 2006). Taken together, the increase in Nox1
and Nox4 and the reduction of eNOS expression in 12 week old
arteries from SHR could be associated with the maintenance of
hypertension.
Ang II signaling through Nox derived ROS can activate MAP
kinases, tyrosine kinases, transcription factors and modulate
intracellular free Ca2+ concentration ([Ca2+]i), participating
in processes like growth, migration, deposition of extracellular
matrix and inflammation (Knock and Ward, 2011). In order
to investigate the effect of Ang II on PDI expression, pre
hypertensive, 7 week-old SHR were treated with AT1 receptor
antagonist. Treatment with losartan decreased blood pressure
and ROS generation in both mesenteric resistance arteries and
aorta. However, only in SHR mesenteric arteries losartan treat-
ment lowered PDI and Nox1 expression to control levels. It is
known that antagonism of AT1 receptor can lower ROS gen-
eration and expression of several NADPH oxidase subunits in
SHR (Zalba et al., 2000; Akasaki et al., 2006), however this is
the first report that Ang II increases PDI expression during the
development of hypertension.
To further investigate the mechanisms involved in this effect,
mesenteric resistance arteries fromWistar and SHR were isolated
and stimulated with Ang II in the presence of PDI non specific
inhibitor bacitracin. PDI inhibition resulted in a reduction in
Ang II induced ERK 1/2 phosphorylation in both strains. It has
been shown that in VSMCs from mesenteric arteries of SHR, the
increase in ROS generation is involved in the increase of EGFR
transactivation and as a consequence, in increased ERK 1/2 phos-
phorylation induced by Ang II (Li et al., 2010). Furthermore, we
have shown that PDI silencing decreases Ang II redox signaling
in aortic VSMCs (Janiszewski et al., 2005) and TNF-α signaling
in endothelial cells (Camargo Lde et al., 2013). Altogether our
results suggest a role for PDI in Ang II increased signaling in
resistance vessels from SHR rats.
One interesting finding of this study is that SHR mesen-
teric arteries presented higher expression of PDI. It has been
reported that increase in one subunit is accompanied by increase
in other subunits of NADPH oxidase (Fukui et al., 1997; Dikalova
et al., 2005). We have previously shown that PDI colocalizes with
NADPH subunits (Janiszewski et al., 2005) and the increased
expression of this protein in SHR reinforces the role of PDI as
a regulatory protein of the oxidase complex. Moreover, Fernan-
des et al. (2009) demonstrated that overexpression of PDI in
rabbit aortic smooth muscle cells resulted in preemptive acti-
vation of NADPH oxidase with enhanced production of ROS.
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Therefore, in the present study increased PDI expression in
resistance mesenteric arteries could account for increased Nox1
expression and activity, and consequently higher ROS generation
and Ang II responses in these vessels.
Altogether our results show that PDI expression increases
concomitantly to Nox1 in resistance arteries during hypertension
development and that this effect is dependent on Ang II signal-
ing through the AT1 receptor. Therefore, PDI could be a novel
regulator of Nox1 signaling in resistance arteries contributing to
oxidative stress and vascular dysfunction in hypertension.
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